GB9714675D0 - Novel composition - Google Patents
Novel compositionInfo
- Publication number
- GB9714675D0 GB9714675D0 GBGB9714675.7A GB9714675A GB9714675D0 GB 9714675 D0 GB9714675 D0 GB 9714675D0 GB 9714675 A GB9714675 A GB 9714675A GB 9714675 D0 GB9714675 D0 GB 9714675D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel composition
- novel
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9714675.7A GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
SK7-2000A SK72000A3 (en) | 1997-07-11 | 1998-07-07 | Novel composition comprising an ssri and a beta-blocker |
APAP/P/1999/001728A AP2000001728A0 (en) | 1997-07-11 | 1998-07-07 | Novel composition. |
CN98806975A CN1262627A (zh) | 1997-07-11 | 1998-07-07 | 新型组合物 |
EA200000112A EA200000112A1 (ru) | 1997-07-11 | 1998-07-07 | Новая композиция |
JP50818599A JP2002508003A (ja) | 1997-07-11 | 1998-07-07 | 新規な組成物 |
AU93401/98A AU9340198A (en) | 1997-07-11 | 1998-07-07 | Novel composition |
CA002295822A CA2295822A1 (en) | 1997-07-11 | 1998-07-07 | Novel composition |
IL13386998A IL133869A0 (en) | 1997-07-11 | 1998-07-07 | Novel composition novel formulations comprising an ssri in combination with a beta blocker |
BR9810996-0A BR9810996A (pt) | 1997-07-11 | 1998-07-07 | Composição farmacêutica |
PCT/EP1998/004971 WO1999002142A2 (en) | 1997-07-11 | 1998-07-07 | Novel composition comprising an ssri and a beta-blocker |
PL98338017A PL338017A1 (en) | 1997-07-11 | 1998-07-07 | Novel composition |
EP98946294A EP0996466A2 (en) | 1997-07-11 | 1998-07-07 | Novel composition comprising an ssri and a beta-blocker |
KR1020007000202A KR20010021644A (ko) | 1997-07-11 | 1998-07-07 | 신규한 조성물 |
HU0003074A HUP0003074A3 (en) | 1997-07-11 | 1998-07-07 | Pharmaceutical composition comprising ssri and betha-blocking agent |
IDW20000035A ID24191A (id) | 1997-07-11 | 1998-07-07 | Komposisi baru |
TR2000/00074T TR200000074T2 (tr) | 1997-07-11 | 1998-07-07 | Yeni terkip |
DZ980166A DZ2556A1 (fr) | 1997-07-11 | 1998-07-08 | Compositions nouvelles d'inhibiteur sélectif de réabsorption de sérotonine et d'un beta-bloquant. |
ZA9806138A ZA986138B (en) | 1997-07-11 | 1998-07-10 | Combinations of selective serotonin re-update inhibitors and B-blockers. |
MA25165A MA24604A1 (fr) | 1997-07-11 | 1998-07-10 | Compositions nouvelles d'inhibiteur selectif de reabsorption de serotonine et d'un b-bloquant |
CO98039260A CO4950552A1 (es) | 1997-07-11 | 1998-07-10 | Nueva composicion lectivos de la reabsorcion de seotonina y un bloqueador b |
PE1998000612A PE99699A1 (es) | 1997-07-11 | 1998-07-10 | Composicion que comprende un inhibidor selectivo de la reabsorcion de serotonina y un �-bloqueante |
ARP980103371A AR016128A1 (es) | 1997-07-11 | 1998-07-10 | Una composicion farmaceutica que comprende un inhibidor de recaptacion de serotonina y un beta-bloqueante y el empleo de la misma para la produccion de unmedicamento. |
NO20000107A NO20000107L (no) | 1997-07-11 | 2000-01-10 | Ny blanding |
OA1200000006A OA11276A (en) | 1997-07-11 | 2000-01-11 | Novel composition comprising an ssri and a beta-b locker. |
BG104119A BG104119A (en) | 1997-07-11 | 2000-02-01 | A new composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9714675.7A GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9714675D0 true GB9714675D0 (en) | 1997-09-17 |
Family
ID=10815744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9714675.7A Pending GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0996466A2 (xx) |
JP (1) | JP2002508003A (xx) |
KR (1) | KR20010021644A (xx) |
CN (1) | CN1262627A (xx) |
AP (1) | AP2000001728A0 (xx) |
AR (1) | AR016128A1 (xx) |
AU (1) | AU9340198A (xx) |
BG (1) | BG104119A (xx) |
BR (1) | BR9810996A (xx) |
CA (1) | CA2295822A1 (xx) |
CO (1) | CO4950552A1 (xx) |
DZ (1) | DZ2556A1 (xx) |
EA (1) | EA200000112A1 (xx) |
GB (1) | GB9714675D0 (xx) |
HU (1) | HUP0003074A3 (xx) |
ID (1) | ID24191A (xx) |
IL (1) | IL133869A0 (xx) |
MA (1) | MA24604A1 (xx) |
NO (1) | NO20000107L (xx) |
OA (1) | OA11276A (xx) |
PE (1) | PE99699A1 (xx) |
PL (1) | PL338017A1 (xx) |
SK (1) | SK72000A3 (xx) |
TR (1) | TR200000074T2 (xx) |
WO (1) | WO1999002142A2 (xx) |
ZA (1) | ZA986138B (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE457169T1 (de) | 1998-10-15 | 2010-02-15 | Imp Innovations Ltd | Verbindungen für die behandlung von gewichtsverlust |
IL142896A0 (en) | 1998-11-02 | 2002-04-21 | Elan Corp Plc | Multiparticulate modified release composition |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
RU2230556C2 (ru) | 1999-10-29 | 2004-06-20 | Эро-Селтик, С.А. | Препаративные формы гидрокодона с контролируемым высвобождением |
GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
AU2002227383B2 (en) | 2000-10-30 | 2004-07-08 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
EP1793818A2 (en) * | 2004-09-17 | 2007-06-13 | Neurocure Ltd. | Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
CN100469356C (zh) * | 2006-09-08 | 2009-03-18 | 山东益康药业有限公司 | 复方阿替洛尔缓释片及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2732335C2 (de) * | 1976-07-27 | 1983-01-20 | Sandoz-Patent-GmbH, 7850 Lörrach | Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten |
CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
AU6776196A (en) * | 1995-08-16 | 1997-03-12 | Eli Lilly And Company | Potentiation of serotonin response |
EP0792649A1 (en) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Treatment of sleep disorders |
-
1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
-
1998
- 1998-07-07 CN CN98806975A patent/CN1262627A/zh active Pending
- 1998-07-07 IL IL13386998A patent/IL133869A0/xx unknown
- 1998-07-07 SK SK7-2000A patent/SK72000A3/sk unknown
- 1998-07-07 EA EA200000112A patent/EA200000112A1/ru unknown
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/xx unknown
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 ID IDW20000035A patent/ID24191A/id unknown
- 1998-07-07 CA CA002295822A patent/CA2295822A1/en not_active Abandoned
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/hu unknown
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/pt not_active Application Discontinuation
- 1998-07-07 JP JP50818599A patent/JP2002508003A/ja active Pending
- 1998-07-07 EP EP98946294A patent/EP0996466A2/en not_active Withdrawn
- 1998-07-07 PL PL98338017A patent/PL338017A1/xx unknown
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/en not_active Application Discontinuation
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/ko not_active Application Discontinuation
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/xx active
- 1998-07-10 MA MA25165A patent/MA24604A1/fr unknown
- 1998-07-10 CO CO98039260A patent/CO4950552A1/es unknown
- 1998-07-10 AR ARP980103371A patent/AR016128A1/es unknown
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/xx unknown
- 1998-07-10 PE PE1998000612A patent/PE99699A1/es not_active Application Discontinuation
-
2000
- 2000-01-10 NO NO20000107A patent/NO20000107L/no not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20000107D0 (no) | 2000-01-10 |
BR9810996A (pt) | 2000-08-08 |
DZ2556A1 (fr) | 2003-02-15 |
PL338017A1 (en) | 2000-09-25 |
CO4950552A1 (es) | 2000-09-01 |
ID24191A (id) | 2000-07-13 |
AP2000001728A0 (en) | 2000-03-31 |
HUP0003074A3 (en) | 2001-12-28 |
JP2002508003A (ja) | 2002-03-12 |
CN1262627A (zh) | 2000-08-09 |
SK72000A3 (en) | 2000-12-11 |
EA200000112A1 (ru) | 2000-10-30 |
AR016128A1 (es) | 2001-06-20 |
WO1999002142A2 (en) | 1999-01-21 |
TR200000074T2 (tr) | 2000-05-22 |
BG104119A (en) | 2000-12-29 |
WO1999002142A3 (en) | 1999-04-15 |
PE99699A1 (es) | 1999-12-21 |
CA2295822A1 (en) | 1999-01-21 |
MA24604A1 (fr) | 1999-04-01 |
EP0996466A2 (en) | 2000-05-03 |
OA11276A (en) | 2003-07-31 |
IL133869A0 (en) | 2001-04-30 |
HUP0003074A2 (hu) | 2001-01-29 |
AU9340198A (en) | 1999-02-08 |
KR20010021644A (ko) | 2001-03-15 |
NO20000107L (no) | 2000-01-10 |
ZA986138B (en) | 2000-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9704524D0 (en) | Composition | |
GB9715203D0 (en) | Composition | |
GB9713620D0 (en) | Composition | |
GB9711683D0 (en) | Composition | |
GB9726543D0 (en) | Novel compositions | |
GB9715489D0 (en) | Composition | |
GB9714010D0 (en) | Composition | |
GB9726777D0 (en) | Composition | |
PL338017A1 (en) | Novel composition | |
EP0958806A4 (en) | HAIR COLORING COMPOSITION | |
GB9701031D0 (en) | Composition | |
GB9714359D0 (en) | Composition | |
GB9726284D0 (en) | Composition | |
GB9826467D0 (en) | Composition | |
GB9724975D0 (en) | Composition | |
GB9705813D0 (en) | Novel compositions | |
GB9705110D0 (en) | Composition | |
EG23068A (en) | Pesticidale composition | |
ZA986934B (en) | Composition | |
GB9718910D0 (en) | Composition | |
GB9722706D0 (en) | Composition | |
GB9722705D0 (en) | Composition | |
GB9723007D0 (en) | Composition | |
GB9708197D0 (en) | Composition | |
GB9726205D0 (en) | Composition |